Device Trial Radar · NCT02570113
The Peregrine Post-Market Study for the Treatment of Hypertension
Last checked: Nov 20, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
45
Actual
Start
Nov 2015
Primary completion
Feb 2019
Study completion Jul 2019
Sponsor
- Lead sponsor
- Ablative Solutions, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 7, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Ablative Solutions, Inc. Peregrine System Infusion Catheter is a catheter-based device which is intended to be used to ablate the afferent and efferent sympathetic nerves serving the kidneys. The catheter is inserted via the femoral artery, steered into the renal artery, and then delivers, by infusion from its distal end, a neurolytic agent. This targets the nerve bundles, which are in the adventitia - a sheath surrounding the artery. The aim is to reduce blood pressure in cases of hypertension, including seriously elevated blood pressure which does not respond to drug treatment. This study will evaluate the safety and performance of the device.
Conditions
- Hypertension
Interventions
Peregrine System Infusion CatheterDevice
The Peregrine Catheter is inserted bilaterally into the renal arteries and a specified amount of a neurolytic agent is inserted into the vessel walls.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With the Absence of Particular Events as Adjudicated by the CEC Through 1-month Post Procedure:Time frame: 1-month
- Change in 24-hour Mean Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsTime frame: 6 months
Locations
10 sites in 4 countries. Site status is shown where the registry gives one.
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Na Homolce Hospital
Prague, Czechia
Charite-Universitaetsmedizin Berlin
Berlin, Germany
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.